Company Search:
Advanced Search
Sponsored Links
Inno-Gene SA Company Snapshot
Inno-Gene SA operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Inno-Gene SA with three other miscellaneous service companies in Europe: Plant Advanced Technologies PAT SA of France (2016 sales of 1.15 million Euro [US$1.41 million] ), Faron Pharmaceuticals Oy of the United Kingdom (£946,543.82 [US$1.31 million] ), and PCI Biotech Holding ASA which is based in Norway (10.48 million Norwegian Kroner [US$1.33 million] ).

Sales Analysis. During the year ended December of 2016, sales at Inno-Gene SA were 4.67 million Polish New Zlotys (US$1.37 million). This is an increase of 11.4% versus 2015, when the company's sales were 4.19 million Polish New Zlotys. This was the fifth consecutive year of sales increases at Inno-Gene SA (and since 2011, sales have increased a total of 142%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Inno-Gene SA
  Stock Performance Chart for Inno-Gene SA
  Stock Data: Recent Stock Performance:
  Current Price (1/18/2018): 3.51
(Figures in Polish New Zlotys)
1 Week 0.3%   13 Weeks 1.7%  
4 Weeks 21.0%   52 Weeks -38.4%  
Inno-Gene SA Key Data:
  Ticker: IGN Country: Poland
  Exchanges: WAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 4,666,229
(Year Ending Jan 2017).
Employees: 16
  Currency: Polish New Zlotys Market Cap: 20,010,794
  Fiscal Yr Ends: December Shares Outstanding: 5,701,081
  Share Type: Akcje Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.